Appeals Board ruling puts Centriq–Dis-Chem partnership on the line

In Circular 48, the CMS signals tougher enforcement against exempted insurers, warning that non-compliant branding and failure to notify regulators will attract decisive action.

Read More

An eerie calm before the storm

While index levels look stable through September’s expiries, concentrated option exposures and rising fund-based covered-call strategies create a fragile backdrop for a sudden move.

Read More